| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Entrust Healthcare is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sawtooth Surgery Center is a Twin Falls, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
First Care Clinic is a 501(c)(3) Nonprofit Federally Qualified Health Center providing healthcare services for people of all ages, regardless of the patient’s ability to pay. They offer family medicine, dental health care, and mental health services al...
Hi-Tech Pharmacal Co., Inc. (Hi-Tech) is a specialty manufacturer and marketer of prescription, over-the-counter (OTC) and nutritional products.